  |  | S&P 500 sets record high but fails to hold 2,000 mark | NEW YORK (Reuters) - The S&P 500 was unable to hold the 2,000 mark after moving above the milestone level for the first time on Monday, but still managed to close at a record high, buoyed by financials and biotechnology stocks. | |  |   |  | Burger King in talks to buy Canada's Tim Hortons | NEW YORK/TORONTO (Reuters) - Burger King is in talks to acquire Canadian coffee and doughnut chain Tim Hortons Inc in a deal that would create a fast food powerhouse with a market capitalization of roughly $18 billion. | |  | |   |  | Roche to buy U.S. biotech firm InterMune for $8.3 billion | LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases. | |  | |  |  |  | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  |  | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | |  | | » MORE NEWSLETTERS | |